These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 34856907)
1. Ameliorating Alzheimer's-like Pathology by Minocycline via Inhibiting Cdk5/p25 Signaling. Zhao Y; Wang C; He W; Cai Z Curr Neuropharmacol; 2022 Aug; 20(9):1783-1792. PubMed ID: 34856907 [TBL] [Abstract][Full Text] [Related]
2. Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer's disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction. Yang W; Xu QQ; Yuan Q; Xian YF; Lin ZX Int Immunopharmacol; 2023 Jan; 114():109504. PubMed ID: 36508924 [TBL] [Abstract][Full Text] [Related]
3. Synaptic deficits are rescued in the p25/Cdk5 model of neurodegeneration by the reduction of β-secretase (BACE1). Giusti-Rodríguez P; Gao J; Gräff J; Rei D; Soda T; Tsai LH J Neurosci; 2011 Nov; 31(44):15751-6. PubMed ID: 22049418 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia increases Aβ-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice. Gao L; Tian S; Gao H; Xu Y J Mol Neurosci; 2013 Sep; 51(1):138-47. PubMed ID: 23345083 [TBL] [Abstract][Full Text] [Related]
5. Reductions in amyloid-beta-derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylation. Parachikova A; Vasilevko V; Cribbs DH; LaFerla FM; Green KN J Alzheimers Dis; 2010; 21(2):527-42. PubMed ID: 20555131 [TBL] [Abstract][Full Text] [Related]
6. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus. Zhang ZX; Zhao RP; Wang DS; Li YB Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086 [TBL] [Abstract][Full Text] [Related]
7. Changes in the prefrontal cortex after the hippocampus was injected with Aβ Wang Y; Sheng H; Zhao J; Guo L; Liu J; Xu J; Liu Q; Huang J; Jiang R; Gan S; Qiu G; Lu W; Xu S; Zhu S Neurosci Lett; 2021 Jan; 741():135453. PubMed ID: 33186609 [TBL] [Abstract][Full Text] [Related]
8. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation. Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667 [TBL] [Abstract][Full Text] [Related]
9. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation. Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757 [TBL] [Abstract][Full Text] [Related]
10. Loss of Endothelial Nitric Oxide Synthase Promotes p25 Generation and Tau Phosphorylation in a Murine Model of Alzheimer's Disease. Austin SA; Katusic ZS Circ Res; 2016 Oct; 119(10):1128-1134. PubMed ID: 27601478 [TBL] [Abstract][Full Text] [Related]
11. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105 [TBL] [Abstract][Full Text] [Related]
12. TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice. Shukla V; Seo J; Binukumar BK; Amin ND; Reddy P; Grant P; Kuntz S; Kesavapany S; Steiner J; Mishra SK; Tsai LH; Pant HC J Alzheimers Dis; 2017; 56(1):335-349. PubMed ID: 28085018 [TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus 9-mediated Cdk5 inhibitory peptide reverses pathologic changes and behavioral deficits in the Alzheimer's disease mouse model. He Y; Pan S; Xu M; He R; Huang W; Song P; Huang J; Zhang HT; Hu Y FASEB J; 2017 Aug; 31(8):3383-3392. PubMed ID: 28420695 [TBL] [Abstract][Full Text] [Related]
14. Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder. Cai Z; Yan Y; Wang Y Clin Interv Aging; 2013; 8():1089-95. PubMed ID: 23983461 [TBL] [Abstract][Full Text] [Related]
15. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study. Zhang ZX; Zhao RP; Wang DS; Wang AN Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601 [TBL] [Abstract][Full Text] [Related]
16. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases. Cai Z; Wang C; He W; Chen Y Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345 [TBL] [Abstract][Full Text] [Related]
17. Deregulated Cdk5 activity is involved in inducing Alzheimer's disease. Shukla V; Skuntz S; Pant HC Arch Med Res; 2012 Nov; 43(8):655-62. PubMed ID: 23142263 [TBL] [Abstract][Full Text] [Related]
18. Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation. Li L; Li WJ; Zheng XR; Liu QL; Du Q; Lai YJ; Liu SQ Mol Med; 2022 Jan; 28(1):11. PubMed ID: 35093024 [TBL] [Abstract][Full Text] [Related]
19. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice. Liu HL; Zhao G; Zhang H; Shi LD Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia. Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]